Expanded terminal sedation in end-of-life care.

Authors:
Gilbertson L; Savulescu J; Oakley J; Wilkinson D.

Journal:
J Med Ethics

Publication Year: 2022

DOI:
10.1136/jme-2022-108511

PMCID:
PMC10086483

PMID:
36543531

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Med Ethics

Abbreviation: J Med Ethics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ethics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of manda…
Bardosh K; Krug A; Jamrozik E and 6 more (2024) - Transparency Score: 4/6
Professional virtue of civility and the responsibilities of medical educators and academic leaders.
McCullough LB; Coverdale J; Chervenak FA. (2023) - Transparency Score: 3/6
The harm principle, personal identity and identity-relative paternalism.
Wilkinson D. (2023) - Transparency Score: 3/6
Where is knowledge from the global South? An account of epistemic justice for a global bioethics.
Pratt B; de Vries J. (2023) - Transparency Score: 3/6
Whose models? Which representations? A response to Wagner.
Hardman D; Hutchinson P. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: JS is a Bioethics Committee consultant for Bayer Pharmaceutical. There are no other COI."

Evidence found in paper:

"Funding: This study was funded by Wellcome (WT203132) and Wellcome Trust (WT203132)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025